A new report warns that sweeping procurement reforms in Mainland China, alongside open robotics platforms, supply chain disruption and GLP-1 drugs, are changing competition and challenging ...

A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over ...

HGF expands European offering with pair of in-house hires ...

A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader ...

Ashurst Perkins Coie opens its doors following landmark merger ...

Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of ...

Despite the flexibilities embedded in the TRIPS Agreement and reaffirmed by the Doha Declaration, timely access to vaccines ...

The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from ...

15 June 2026 Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech ...

The court granted Blue Cross Laboratories a permanent injunction after finding that a rival product’s mark and packaging closely mirrored its own.